Article History
Received: 13 June 2021
Accepted: 15 October 2021
First Online: 26 October 2021
Declarations
:
: This study was approved by the Institutional Review Board of the Research Ethics Committee of Taichung Tzu Chi Hospital (REC109-64) and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable (anonymized retrospective study).
: The authors are responsible for correctness of the statements provided in the manuscript.
: Ching-Fu Wang is a shareholder of Neurobit Technologies, which is a Taiwanese multinational corporation that designs and manufactures comprehensive neuro-otological diagnostic system for better patient care.Other authors declare no competing interests.